Own Sonic Healthcare shares? Here's a look at the state of its balance sheet

Fundamentals are becoming increasingly important again in this current investment landscape

| More on:
Doctor reading a file

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Key points

  • Sonic is a healthcare giant that has built up a bastion of cash and assets over the years 
  • With the probability of economic risks increasing, we take a closer look at Sonic's balance sheet
  • In the last 12 months, the Sonic share price has slipped around 12%

The Sonic Healthcare Ltd (ASX: SHL) share price had a turbulent time in FY22. After surging to 52-week highs of $46.71 on 30 December, the company's shares then cratered to $32.22 by 8 March.

After a relief rally, Sonic was trading sideways until June, but has since walked back towards its yearly lows, as seen below.

TradingView Chart

The forward-looking climate demands more from companies in terms of cash (liquidity and working capital) management.

With that in mind, let's take a look at Sonic's balance sheet to gain some insight into how it might weather any potential economic storm.

Sonic balance sheet breakdown

The most recent snapshot of Sonic's financial health was supplied within its set of half-yearly accounts back in February.

At that time, the company had cash and marketable securities of $735.3 million, down 18% from the previous year.

Shareholder equity totalled $7.26 billion, made up of $12.5 billion in total assets and $5.24 billion in total liabilities.

Let's take a deeper dive into how Sonic is managing cash and working capital.

Sonic should meet its short-term obligations when they fall due. Short-term liabilities are covered 1.1x by short-term assets (current ratio). That's one check for the Sonic Healthcare share price.

Meanwhile, the ratio of debt to assets is 26%, meaning debt holders have financed Sonic's asset base by that amount.

The long-term debt to total capital ratio is 28% suggesting the company has low leverage. It also has around $1 billion in long-term lease obligations.

Further insights to consider for the Sonic share price

Linking the balance sheet with some figures on the income statement gives further insights.

Sonic turned over its inventory 6.3 times in H1 FY22 and generated 75 cents for every dollar invested into its asset base.

It also generated a 12% return on assets and return on invested capital of 16% for the half as well. This is well above the company's cost of capital of 7%.

From this data, we can make a few inferences. First, Sonic can cover its short-term obligations when they come due.

It also is lowly-leveraged, with debt making up less than 30% of its capital structure. That's important in a world of rising interest rates.

It is also generating a decent return on its assets and invested capital that is above what it costs to acquire that capital.

These could be defensible characteristics in the event of an economic downturn. Remember, the balance sheet illustrates the financial health of the company, and these ratios give further insights.

In the last 12 months, the Sonic share price has slipped 12% into the red.

Sonic's asset and liability growth since 2018 is plotted on the chart below.

TradingView Chart

Motley Fool contributor Zach Bristow has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has recommended Sonic Healthcare Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Healthcare Shares

a biomedical researcher sits at his desk with his hand on his chin, thinking and giving a small smile with a microscope next to him and an array of test tubes and beackers behind him on shelves in a well-lit bright office.
Healthcare Shares

Broker says this ASX 200 biotech stock is a top buy

Let's see what Bell Potter is saying about this biotech.

Read more »

Cropped shot of an attractive young female scientist working on her computer in the laboratory.
Healthcare Shares

Why CSL shares are a buy today despite the looming Trump tariffs

A leading expert believes CSL shares are still trading for a bargain today. Here's why.

Read more »

A businesswoman pulls her glasses down in shock to look at the bad news on her computer.
Healthcare Shares

Why did the Telix share price just crash 16%?

Investors are sending the Telix share price plunging today. But why?

Read more »

Broker analysing the share price.
Healthcare Shares

Expert: 2 ASX healthcare stocks to avoid before reporting season

Not all healthcare stocks are created equal.

Read more »

A group of people in a corporate setting do a collective high five.
Healthcare Shares

Should I buy Pro Medicus or CSL shares ahead of earnings season?

The ASX healthcare sector may be currently undervalued.

Read more »

Overjoyed man celebrating success with yes gesture after getting some good news on mobile.
Healthcare Shares

Why Mesoblast shares can keep storming higher

More big returns could be on the way for buyers of this high risk stock according to Bell Potter.

Read more »

Doctor doing a telemedicine using laptop at a medical clinic
Healthcare Shares

The Mesoblast share price just rocketed 38%! Here's why

ASX investors just sent the Mesoblast share price up 38%. But why?

Read more »

couple having a happy discussion with a banker
Healthcare Shares

Expert: 4 ASX healthcare stocks to buy ahead of reporting season

Could these ASX healthcare stocks be good additions to your portfolio?

Read more »